Drug firm Elder Pharmaceuticals today posted a 47 per cent surge in consolidated net profit to Rs 13.68 crore for the quarter ended September 30, 2010.
The company had registered a net profit of Rs 9.30 crore in the second quarter ended September 30, 2009, Elder Pharmaceuticals said in a statement.
During the quarter, the company's income from operations stood at Rs 210.65 crore, compared to Rs 174.95 crore in the corresponding period last fiscal.
The company also said it raised around Rs 69.70 crore during the quarter through qualified institutional placement.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app